Studies

Infliximab vs cyclosporine in ASUC

Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with CD

Granulocyte/Monocyte Apheresis in UC

Allogeneic adipose-derived mesenchymal stem cells (Cx601) in perianal CD

Effect of no-carrageenan diet in UC activity

Tofacitinib for induction and maintenance therapy of Crohn’s disease: results of two phase IIb randomised placebo-controlled trials

PF-00547659 in UC

Topical tacrolimus in UC proctitis

Phase 2 trial Risankizumab in Crohn’s disease

Tofacitinib in UC